Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.840
-0.150 (-3.76%)
At close: Nov 16, 2026, 4:00 PM EST
3.925
+0.085 (2.20%)
After-hours: Nov 16, 2026, 7:59 PM EST

Nuvation Bio Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $12.45. The average 1-year stock price forecast is 224.22% higher than the current stock price, while the lowest is $7.00 (+82.29%) and the highest is $21 (+446.88%).

Price Target: $12.45 (+224.22%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$12.45$12$21
Change+82.29%+224.22%+212.50%+446.88%

Analyst Ratings

The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy778999
Buy223333
Hold111111
Sell000000
Strong Sell000000
Total101012131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JonesTrading
JonesTrading
Buy
Maintains
$12
BuyMaintains$12+212.50%Nov 16, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$13 → $11
BuyReiterates$13 → $11+186.46%Nov 9, 2026
Wedbush
Wedbush
Buy
Maintains
$11
BuyMaintains$11+186.46%Nov 6, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$14 → $13
BuyMaintains$14 → $13+238.54%Nov 5, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$20 → $17
BuyReiterates$20 → $17+342.71%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
203.17M
from 62.90M
Increased by 222.99%
Revenue Next Year
250.89M
from 203.17M
Increased by 23.49%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.08
from -0.29
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---7.87M62.90M203.17M
Revenue Growth
----698.96%222.99%
Gross Profit
---795.00K53.60M171.01M
Gross Margin
---10.10%85.22%84.17%
Operating Income
-89.53M-119.73M-99.82M-167.56M-213.06M-132.53M
Net Income
-86.85M-104.20M-75.80M-567.94M-204.63M-137.25M
EPS
-----0.49-0.29
Free Cash Flow
-----173.78M-101.27M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High236.4M
Avg203.2M
Low190.6M

Revenue Growth

Revenue Growth202620272028
High
275.9%
Avg
223.0%
Low
203.0%

EPS Forecast

EPS202620272028
High-0.28
Avg-0.29
Low-0.30

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-